Fingerprint
Dive into the research topics of 'First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically